Bullseye Biosciences

unknown
unknown
Stage
1
Investors

About

Bullseye Biosciences uses directed evolution inside living cells to discover functional therapeutic molecules targeting challenging intracellular proteins, focusing on intracellular protein interactions and transcriptional regulation relevant to diseases like cancer.

Explore Bullseye Biosciences's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.